Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.
D000328:Adult; D003404:Creatinine / Q000652:urine; D004357:Drug Synergism; D006801:Humans; D007210:Indoleacetic Acids / Q000652:urine; D008297:Male; D008715:Methionine / Q000008:administration & dosage / Q000494:pharmacology*; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism* / Q000652:urine; D012565:Schizophrenic Psychology; D014191:Tranylcypromine / Q000627:therapeutic use*; D014363:Tryptamines / Q000652:urine; D014364:Tryptophan / Q000008:administration & dosage / Q000494:pharmacology*
D007210:Indoleacetic Acids; D014363:Tryptamines; D014191:Tranylcypromine; D014364:Tryptophan; D008715:Methionine; D003404:Creatinine